Empire Genomics

Empire Genomics is a leading biotechnology company focused on the development of advanced molecular diagnostics and genomic products. Our mission is to accelerate precision medicine by providing tools that empower researchers, clinicians, and pharmaceutical companies to better understand, diagnose, and treat complex diseases, particularly in oncology. We offer an extensive portfolio of FISH (Fluorescence In Situ Hybridization) probes, ancillary reagents, and custom assay development services. These products are essential for detecting genetic abnormalities, such as gene amplifications, deletions, and rearrangements, critical for diagnosing and monitoring various cancers and genetic disorders. Committed to quality and innovation, our products are rigorously tested...

Molecular diagnostics,customized fish assays,personalized medicine,custom assays,cytogenetics,molecular biology,and automation

Empire genomics operates in the Biotechnology research industry.

Empire genomics's revenue is 11m - 100m

Empire genomics has 11 - 50 employees.